Tag: Bayer

Bayer announces start of Phase 2 GenePHIT trial for AB-1002

businessnewstoday- February 17, 2024

Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More

Bayer and Sun Pharma join forces for new brand of Finerenone in India

businessnewstoday- January 17, 2024

In a significant development for the Indian healthcare sector, Sun Pharmaceutical Industries Limited and Bayer have announced a collaborative agreement to market and distribute a ... Read More

Bayer gets Ultravist FDA approval for contrast-enhanced mammography

businessnewstoday- June 23, 2023

Bayer has received US Food and Drug Administration (FDA) approval for Ultravist (iopromide) injection, its iodine-based contrast agent, to be used for contrast-enhanced mammography (CEM). ... Read More

Bayer selects OpenText Business Network Cloud Enterprise for B2B integration

businessnewstoday- March 1, 2023

OpenText said that German healthcare major Bayer has selected OpenText Business Network Cloud Enterprise as a solution for certain B2B integration activities within the consumer ... Read More

Bayer acquires Scottish imaging AI platform provider Blackford Analysis

Raghuram Kadari- January 21, 2023

Bayer has acquired Blackford Analysis, a Scottish imaging artificial intelligence (AI) platform, to strengthen its footprint in the digital medical imaging market. The acquisition forms ... Read More

Bayer to sell men’s health product Nebido to Grünenthal in €500m deal

pallavi123- July 17, 2022

Bayer has agreed to sell Nebido (testosterone undecanoate), its men’s health product, to German pharma company Grünenthal for a price of up to €500 million. ... Read More

US agri and biotech innovator Andes Ag, Inc. raises $15m in Series A round

businessnewstoday- September 14, 2021

Andes Ag, Inc., an agriculture and biotechnology innovator based in California, has raised $15 million in a Series A round co-led by Bayer’s impact investment ... Read More

Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer

pallavi123- April 11, 2021

Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent ... Read More

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

pharmanewsdaily- October 26, 2020

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio ... Read More

Bayer to acquire KaNDy Therapeutics to add menopause drug candidate

pharmanewsdaily- August 11, 2020

Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow ... Read More